Standard Biotools (LAB) Construction in Progress (2011 - 2026)
Standard Biotools (LAB) posted quarterly Construction in Progress of $823000.0 for Q1 2026, down 88.23% year-over-year from $7.0 million in Q1 2025, and down 8.56% quarter-over-quarter from $900000.0 in Q4 2025.
Standard Biotools (LAB) Construction in Progress (2011 - 2026) Analysis & Trends
Standard Biotools (LAB) has reported Construction in Progress for 16 consecutive years, with $823000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Construction in Progress fell 88.23% year-over-year to $823000.0; the TTM figure through Mar 2026 stood at $823000.0 (down 88.23% YoY), while the FY2025 annual figure was $900000.0, down 85.07% from the prior year.
- Construction in Progress eased to $823000.0 in Q1 2026 per LAB's latest filing, from $900000.0 in the prior quarter.
- Across five years, Construction in Progress topped out at $7.0 million in Q1 2025 and bottomed at $375000.0 in Q3 2025.
- Historically, Construction in Progress has averaged $2.8 million across 5 years, with a median of $2.1 million in 2022.
- Annual changes were most pronounced in 2024 — Construction in Progress soared 205.84% — and 2025, when it sank 93.97%.
- Standard Biotools' Construction in Progress stood at $1.6 million in 2022, then jumped by 44.79% to $2.3 million in 2023, then soared by 158.27% to $6.0 million in 2024, then tumbled by 85.07% to $900000.0 in 2025, then dropped by 8.56% to $823000.0 in 2026.
- Business Quant data shows LAB's Construction in Progress at $823000.0 in Q1 2026, $900000.0 in Q4 2025, and $375000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Construction in Progress (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | - |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | - |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 911.00 Mn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | - |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | - |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | - |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 455.10 Mn |
| 10 | Standard Biotools | 250.59 Mn | -226.13 Mn | 10.54 Mn | 560,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 560,000.00 |
| Mar 31, 2026 | 823,000.00 |
| Dec 31, 2025 | 900,000.00 |
| Sep 30, 2025 | 375,000.00 |
| Jun 30, 2025 | 473,000.00 |
| Mar 31, 2025 | 6.99 Mn |
| Dec 31, 2024 | 6.03 Mn |
| Sep 30, 2024 | 6.22 Mn |
| Jun 30, 2024 | 5.35 Mn |
| Mar 31, 2024 | 4.81 Mn |
| Dec 31, 2023 | 2.33 Mn |
| Sep 30, 2023 | 3.05 Mn |
| Jun 30, 2023 | 2.29 Mn |
| Mar 31, 2023 | 1.57 Mn |
| Dec 31, 2022 | 1.61 Mn |
| Sep 30, 2022 | 1.47 Mn |
| Jun 30, 2022 | 2.08 Mn |
| Mar 31, 2022 | 1.66 Mn |
| Dec 31, 2021 | 4.55 Mn |
| Sep 30, 2021 | 22.00 Mn |